๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ifosfamide, methotrexate, and 5-fluorouracil: effective combination in resistant breast cancer

โœ Scribed by N. Gad-El-Mawla; M. R. Hamza; Z. K. Zikri; M. Elserafi; A. El-Khodari; H. Khaled; R. Gafaar

Publisher
Springer
Year
1990
Tongue
English
Weight
200 KB
Volume
26
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combination chemotherapy for metastatic
Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate
โœ Ambrose Aboud; Aman U. Buzdar; Hwee-Yong Yap; Gabriel N. Hortobagyi; George R. B ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 270 KB

Twenty-nine patients with metastatic breast cancer were treated with fluorouracil, adriamycin, cyclophosphamide (FAC), and methotrexate (MTX), with or without leukovorin rescue. Of 24 evaluable patients, one achieved a complete remission and 17 had partial responses. The overall objective response r

An effective low-dose intermittent cyclo
An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer
โœ Richard H. Creech; Robert B. Catalano; Michael J. Mastrangelo; Paul F. Engstrom ๐Ÿ“‚ Article ๐Ÿ“… 1975 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 571 KB

A low-dose, three-drug regimen, C.M.F. (cyclophosphamide 50 mg, P.o., days 1-14; methotrexate, 25 mg, and 5-fluorouracil, 500 mg, i.v., days 1 and 8; cycled every 28 days) was used in 46 consecutive chemotherapy-eligible women (41 previously hormonally treated) with recurrent breast cancer. Thirteen